A phase I study of the single-agent CDK4/6 inhibitor LEE011 in pts with advanced solid tumors and lymphomas.
暂无分享,去创建一个
G. Shapiro | J. Infante | V. Ribrag | J. Gerecitano | P. Witteveen | A. Chakraborty | R. Chugh | A. Matano | S. Parasuraman | Israel Issa | Xumei Zhao | P. Cassier